|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2008-10-9
|
|
pubmed:abstractText |
To compare the prediction of therapeutic hepatic radiation-absorbed dose rates from tracer imaging plus a linearity assumption to estimation based on intra-therapy imaging in (131)I metaiodobenzylguanidine (MIBG) therapy of refractory neuroblastoma.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1619-7089
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
35
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2105-12
|
|
pubmed:meshHeading |
pubmed-meshheading:18682939-3-Iodobenzylguanidine,
pubmed-meshheading:18682939-Absorption,
pubmed-meshheading:18682939-Adolescent,
pubmed-meshheading:18682939-Child,
pubmed-meshheading:18682939-Child, Preschool,
pubmed-meshheading:18682939-Female,
pubmed-meshheading:18682939-Humans,
pubmed-meshheading:18682939-Liver,
pubmed-meshheading:18682939-Male,
pubmed-meshheading:18682939-Models, Biological,
pubmed-meshheading:18682939-Neuroblastoma,
pubmed-meshheading:18682939-Radiation Dosage,
pubmed-meshheading:18682939-Radiometry
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Hepatic absorbed radiation dosimetry during I-131 metaiodobenzylguanidine (MIBG) therapy for refractory neuroblastoma.
|
|
pubmed:affiliation |
Department of Radiology, Nuclear Medicine Division, University of Michigan, Ann Arbor, MI, USA. kenkoral@umich.edu
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
